AZACITIDINE FOR INJECTION
Google image searchProduct monograph
Active ingredient
azacitidine, 100 MG/VIAL
DIN: 02505177
Dosage form(s): POWDER FOR SUSPENSION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE USE
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 15-OCT-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC07 — AZACITIDINE (ATC/DDD)
Reference brand drug: Vidaza, Onureg
Pharmaceutical standard: MFR
